Browsing by Subject "warfarin"

Now showing items 1-4 of 4

Genetic variants of CYP2C9 and VKORC1 in patients with LVAD

Rakhimova, S.; Akilzhanova, A.; Zhalbinova, M.; Andossova, S.; Bekbossynova, M. (National Laboratory Astana, Nazarbayev University, 2017-09-15)
Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation

Akpanova, D.; Berkinbayev, S.; Ospanova, D.; Musagaliyeva, A. (National Laboratory Astana, Nazarbayev University, 2017-09-15)
Influence of Gamma-glutamyl carboxylage (GGCX) on warfarin dose

Zhalbinova, M.; Rakhimova, S.; Bekbosynova, M.; Myrzakhmetova, Sh.; Akilzhanova, A. (National Laboratory Astana, NAZARBAYEV UNIVERSITY, 2016-05)

Warfarin is an oral anticoagulant which is popular in cardiology for the prevention and treatment of thromboembolic events in patients with deep vein thrombosis. Patients usually treated according to the clinical data. ...
WARFARIN DOSING FOR PATIENTS WITH IMPLANTED MECHANICAL CIRCULATORY SUPPORT DEVICE

Жалбинова, М.Р.; Рахимова, С.Е.; Бекбосынова, М.С.; Андосова, С.А.; Акильжанова, А.Р. (International conference "MODERN PERSPECTIVES FOR BIOMEDICAL SCIENCES: FROM BENCH TO BEDSIDE”; National Laboratory Astana, 2020)

Introduction: Nowadays, implantation of the left ventricular assist device (LVAD) is the alternative way for the treatment of chronic heart failure in Kazakhstan at the National Research Cardiac Surgery Center, since ...